Closing the HPV Testing Gap Act
To direct the Director of the National Institutes of Health to conduct a study and submit to Congress a report on the development of a standardized, noninvasive test for HPV in men, and for other purposes.
HB8939, also known as the Closing the HPV Testing Gap Act, aims to address the lack of standardized, noninvasive HPV testing options for men. The bill directs the Director of the National Institutes of Health to study and report on the development of such a test, with the goal of improving men's access to accurate and convenient HPV screening. This could ultimately lead to better detection and treatment of HPV-related conditions in men.
If passed, the bill would affect healthcare providers, men who may benefit from improved HPV testing, and the research community. By enhancing HPV testing options for men, the bill seeks to improve public health outcomes and reduce the incidence of HPV-related diseases.
As of May 20, 2026, HB8939 was introduced in the House and referred to the House Committee on Energy and Commerce. No further actions have been taken yet, but the bill is in its initial stages of review and consideration.
